Dietary supplementation with hydrolyzed yeast and its effect on the performance, intestinal microbiota, and immune response of weaned piglets

Abstract

The objective of this study was to evaluate the effects of autolyzed yeast on performance, cecal microbiota, and leukogram of weaned piglets. A total of 96 piglets of commercial line weaned at 21-day-old were used. The experimental design was a randomized block design with four treatments (diets containing 0.0%, 0.3%, 0.6%, and 0.9% autolyzed yeast), eight replicates, and three animals per pen in order to evaluate daily weight gain, daily feed intake, and feed conversion in periods of 0 to 15, 0 to 26, and 0 to 36 days. Quadratic effects of autolyzed yeast inclusion were observed on the feed conversion from 0 to 15 days, on daily weight gain from 0 to 15 days, 0 to 26 days and, 0 to 36 days, indicating an autolyzed yeast optimal inclusion level between 0.4% and 0.5%. No effect from autolyzed yeast addition was observed on piglet daily feed intake, cecal microbiota, and leukogram; however, i.m. application of E. coli lipopolysaccharide reduced the values ​​of total leukocytes and their fractions (neutrophils, eosinophils, lymphocytes, monocytes, and rods). Therefore, autolyzed yeast when provided at levels between 0.4% and 0.5% improved weaned piglets’ performance.

Key words immune system; leukogram; nutrition; swine; weaning

INTRODUCTION

In commercial swine production system, early-weaning is a common management practice. It causes great stress to the piglets and results in low feed intake (Leibbrandt et al. 1975, Le Dividich & Sève 2000), impairment of intestinal mucosal integrity (Hampson et al. 1986, Pluske et al. 1997, Spreeuwenberg et al. 2001), and predisposition for disease occurrence (Morés & Amaral 2001) in the post-weaning period.

Thus, in order to minimize the impact of weaning and other environmental challenges, a nutritional strategy is utilized in production system by using ingredients with high digestibility and additives in pre-starter and starter diets. However, in face of increasing restrictions on the use of some of these additives (e.g. antibiotics), interest has increased in studies on functional ingredients, such as autolyzed yeast (AY), which is rich in beta-glucans, favoring immune response mechanisms (Goodridge et al. 2009, Saleh et al. 2015), mannan-oligosaccharides, which have prebiotic action (Spring et al. 2000) and, nucleotides, which are important for the repair and development of fast-growing tissues such as, the intestinal mucosa (Yamamoto et al. 1997).

The yeast cell wall consists of three major groups of polysaccharides: mannose polymers (mannoproteins), glucose polymers (beta-glucans), and N-acetylglucosamine polymers (chitin) that make up over 90% of it, whereas only small and variable amounts of lipid have been reported (Aguilar-Uscanga & François 2003). However, monogastric animals do not have enzymes to digest polysaccharides such as those present in the yeast cell wall, which compromises the animal’s access to these intracellular constituents (cytoplasmic proteins, storage carbohydrates, and membrane-bound subcellular structures, such as mitochondria, the nucleus, and the vacuole, as well as, peptides, nucleic acids, vitamins of B complex and, minerals, mainly K) (Hunter & Asenjo 1988). Therefore, ways to breakdown yeast cell walls have been developed to improve the bioavailability of yeast components for animal nutrition.

According to Liu et al. (2016), the methods used for the breakdown of the yeast cell wall to isolate the bioactive compounds may be mechanical (ball mill grinding, high-pressure homogenization, and ultrasound extraction) or non-mechanical (electrical, enzymatic, physical, and chemical). AY is a dried yeast cell product, obtained as a by-product of the sugar cane alcohol production process and submitted to the process of autolysis (Nogueira et al. 2017). Autolysis occurs when live yeasts are subjected to controlled conditions of pH, temperature and to drying, usually performed in a spray-drying process.

The objective of this research was to evaluate the effects of the dietary inclusion of autolyzed yeast (Saccharomyces cerevisiae) on the performance (daily feed intake, daily weight gain, and feed conversion), intestinal microbiota, and leukograms of weaned piglets.

MATERIALS AND METHODS

All experimental procedures were previously approved by the Animal Ethics Commitee of the Veterinary Medicine and Animal Science College from São Paulo University (USP), under protocol number 3184160317 and, in accordance with directive 2010/63/EU.

Ninety-six commercial hybrids piglets weaned at average age of 21-day-old and with an average initial body weight of 6.00 ± 0.3 kg were distributed in a randomized block design (eight replicates) for evaluating the growth performance of animals receiving diets containing 0.0%, 0.3%, 0.6%, and 0.9% AY for 36 days. The criteria for the formation of the blocks were sex and initial body weight.

The piglets were housed in groups of three animals per 1.70-m² metal nursery pens, equipped with a feeder, a nipple-type drinker, and a heater with electric resistance. During the experimental period, the animals received feed and water ad libitum, and the air temperature inside the experimental barn was controlled and recorded, with mean minimum and maximum temperatures of 18°C ± 2.17°C and 25°C ± 1.54°C, respectively.

According to manufacturer, the AY product had 3.5% of Nu, 22% of B-Gl; 12% of MOS. Thus, its inclusion at 0.3% to 0.9% in piglet diets provided 105 to 315 ppm of Nu; 660 to 1980 ppm of B-GL and, 360 to 1080 ppm of MOS. The following average AY composition was established in the formulation of the diets: 95.15% dry matter, 41.10% crude protein, 2.51% ether extract, 7.04% mineral matter, 1.40% crude fiber, 0.17% calcium, 0.56% total P, 0.19% available P, 2.14% digestible Ile, 3.14% digestible Lys, 0.76% digestible Met, 2.10% digestible Thr, 0.40% digestible Trp, 2.22% digestible Val, and 1.03% digestible S-containing amino acids. The available P and digestible amino acid values were estimated considering the P availability and amino acid digestibility coefficients of yeast from alcohol distillery recommended by Rostagno et al. (2011). The other nutritional values established in formulation were obtained by laboratorial analyses.

The established inclusion levels of AY were based on results of previous studies (Jiang et al. 2015, Shen et al. 2009) and, its inclusion in diets was performed by replacing the corresponding amount of soybean meal 45%.

The piglets received three types of diets: pre-starter 1, pre-starter 2, and starter diets from 21 to 36 days, from 36 to 47 days, and from 47 to 63 days of age, respectively. In the formulation of the experimental diets (Tables I and II), we sought to meet the nutritional requirements proposed by Rostagno et al. (2011).

Table I
Percentage of pre-starter1 (PS1), pre-starter 2 (PS2), and starter (S) diets.

Ingredients (%)	PS1	PS2	S
Corn	51.745	55.675	63.565
Soybean meal 45%	20.000	24.000	29.000
SPC 60%1	3.000	2.500	-
Whey	3.300	2.000	-
Milk concentrate2	3.000	1.000	-
Sugar	4.000	3.000	-
Maltodextrin	4.000	2.000	-
Soy oil	2.500	2.800	2.310
Corn gluten 60%	2.500	2.000	1.000
Limestone	0.820	0.880	0.860
Dicalcium phosphate	1.680	1.560	1.520
Sodium chloride	0.500	0.500	0.500
L-Lysine HCl 78%	0.870	0.630	0.400
DL-Methionine 99%	0.300	0.210	0.110
L-Threonine 98%	0.340	0.220	0.110
L-Tryptophan 98%	0.080	0.050	0.010
L-Isoleucine 99%	0.140	0.020	-
L-Valine 99%	0.270	0.140	-
Zinc oxide 76%	0.340	0.200	-
Tiamulin 10%	0.010	0.010	0.010
Chloride choline 60%	0.090	0.090	0.090
Adsorbent3	0.250	0.250	0.250
B.H.T.4	0.015	0.015	0.015
Mineral premix5	0.100	0.100	0.100
Vitamin premix6	0.150	0.150	0.150
Autolyzed yeast7	0.000	0.000	0.000
Total	100.00	100.00	100.00

• ¹Soy protein concentrate; ²Nutrient information (%): crude protein 4.0; ether extract 1.5; lactose 73.00; crude fiber 0.01; calcium 0.88; phosphorus 1.05; amino acids, digestible: lysine 0.22; threonine 0.12; tryptophan 0.04; cystine 0.21; methionine 0.07; isoleucine 0.12; valine 0.11; metabolizable energy 3,202 kcal/kg; ³Commercial product: Notox, calcium-sodium aluminosilicate; ⁴B.H.T.: butylated hydroxytoluene antioxidant; ⁵Mineral premix providing per kg of feed: Fe 100 mg, Cu 10 mg, Se 30 mg, Mn 40 mg, Zn 100 mg, Co 1 mg, and I 1.5 mg; ⁶Vitamin premix providing per kg of feed: vitamin A 9,000 I.U., vitamin D₃ 2,250 I.U., vitamin E 22.5 mg, vitamin K₃ 22.5 mg, vitamin B₁ 2.03 mg, vitamin B₂ 6 mg, vitamin B₆ 3 mg, vitamin B₁₂ 30 µg, folic acid 0.9 mg, pantothenic acid 14.03 mg, niacin 30 mg, biotin 0.12 mg and, choline 400 mg; ⁷The inclusion of 0.30%, 0.60% and 0.90% AY in the diets was performed by replacing the corresponding amount of soybean meal 45%.

Table II
Calculated (CNV) and analyzed (ANV) nutritional values of pre-starter (PS1 and PS2) and starter (S) diets.

	PS1				PS2				S
	0.0% AY	0.3% AY	0.6% AY	0.9% AY	0.0% AY	0.3% AY	0.6% AY	0.9% AY	0.0% AY	0.3% AY	0.6% AY	0.9% AY
CNV
ME1	3,378	3,378	3,378	3,378	3,365	3,365	3,365	3,365	3,298	3,298	3,298	3,298
CP2	18.52	18.51	18.50	18.48	19.24	19.23	19.21	19.20	19.21	19.20	19.19	19.18
Ca3	0.82	0.82	0.82	0.82	0.80	0.80	0.80	0.80	0.77	0.77	0.77	0.77
Total P4	0.65	0.65	0.65	0.65	0.62	0.62	0.62	0.62	0.61	0.61	0.61	0.61
Dig. P5	0.45	0.45	0.45	0.45	0.41	0.41	0.41	0.41	0.38	0.38	0.38	0.38
Dig. Lys6	1.45	1.45	1.45	1.45	1.33	1.33	1.33	1.34	1.17	1.17	1.17	1.18
Dig. Met7	0.55	0.55	0.55	0.55	0.47	0.47	0.47	0.47	0.37	0.37	0.37	0.37
Dig. Thr8	0.91	0.91	0.91	0.91	0.84	0.84	0.84	0.84	0.74	0.74	0.74	0.74
Dig. Trp9	0.25	0.25	0.25	0.25	0.24	0.24	0.24	0.24	0.21	0.21	0.21	0.21
Dig. Met+Cys10	0.81	0.81	0.81	0.81	0.75	0.74	0.74	0.74	0.65	0.65	0.65	0.65
Dig. Ile11	0.80	0.80	0.80	0.80	0.73	0.73	0.73	0.73	0.72	0.72	0.72	0.72
Dig. Val12	1.00	1.00	1.00	1.00	0.92	0.92	0.92	0.93	0.80	0.80	0.80	0.80
ANV
CP2	18.60	18.36	18.40	18.28	19.10	19.00	19.20	19.00	19.00	19.15	18.90	19.04
Ca3	0.84	0.83	0.82	0.83	0.81	0.79	0.81	0.80	0.78	0.76	0.75	0.76
Total P4	0.63	0.61	0.64	0.63	0.62	0.61	0.64	0.63	0.62	0.61	0.61	0.60

• ¹ Metabolizable energy (kcal/kg); ² Crude protein (%); ³ Total Ca (%); ⁴ Total P (%); ⁵ Digestible P (%); ⁶ Digestible Lys (%); ⁷ Digestible Met (%); ⁸ Digestible Thr (%); ⁹ Digestible Trp (%); ¹⁰ Digestible Met+Cys (%); ¹¹ Digestible Ile (%); ¹² Digestible Val (%).

The growth performance (mean daily feed intake, mean daily gain, and feed conversion) was assessed from the weighing of the animals at the initial, 15^th, 26^th, and 36^th days of the experiment, based on the feed provided and the feed leftovers.

The slaughter was performed on the 40^th day of experiment, for isolation and removal of the cecum, 4 days after the last weighing of the growth performance evaluation. In six of the eight replicates per treatment, one piglet was slaughtered that was closest to the average pen weight, comprising a total of 24 piglets, for determination of total coliform, Escherichia coli, and lactic-acid bacteria counts in the cecum contents.

After slaughter, the animals’ ceca were sent to the laboratory in refrigerated isothermal boxes. Each cecum was opened with sterile tweezers and scalpel, 25 g of the cecal contents was weighed into sterile bags, and 225 mL of 0.1% buffered peptone water (0.1% BPW) was added, obtaining a dilution of 10^-1. From the first dilution, serial dilutions were performed in test tubes containing 9 mL of 0.1% BPW until a 10^-9 dilution was reached.

The coliforms and E. coli counts were counted using Petrifilm plating (Plate 3M™ Petrifilm™ for counting the E. coli coliforms), with 1 mL of the 10^-1, 10^-3, 10^-5, 10^-7, and 10^-9 dilutions being placed in each Petrifilm plate, followed by incubation at 35°C ± 1°C for approximately 48-h. During reading, plates that had between 15 and 150 colonies were considered countable, with the colonies being classified as coliforms and E. coli according to the manufacturer’s specification.

For the counts of lactic-acid bacteria, 1 mL of the 10^-1, 10^-3, 10^-5, 10^-7,and 10^-9dilutions was inoculated into individual plates using the “pour plate” method. A volume between 18 mL and 20 mL of agar medium MRS (OXOID) was added to the inoculated plates; then, homogenization was carried out, and after solidification, 10 mL of the same medium was added for the overlay insert. Plates were incubated at 30°C ± 1°C for 48-h. During reading, plates with 25 to 250 colonies were considered countable, and from the plates read in this interval, five colonies were removed to proceed the catalase test and gram staining, according to APHA (1992). Colonies with gram-positive and catalase-negative cocci/bacilli were classified as lactic-acid bacteria. The calculation of the number of colony-forming unit/g (CFU/g) was based on the proportion of colonies confirmed as lactic-acid and the dilution used in the count.

On the day following slaughter, one of the two remaining piglets per pen (for a total of 32 animals) was randomly selected and given intramuscular injections of 80 μg/kg body weight lipopolysaccharide (LPS) of the cell wall of Escherichia coli serotype 055:B5 (Sigma Aldrich L2880, St. Louis, MO) dissolved in 1.0 mL of 0.01 M saline (PBS) at pH 7.4. Immediately prior to application and within 2 to 3 hours after application of the LPS, blood was collected by vacuum system (4 mL tubes) using 40 x 9-mm needles to determine the total and differential leukocyte count using an automatic veterinary cell counter (MC-6200 vet cell, Shenzhen Maxcom 59 Electronic, China).

For all variables studied, a regression analysis was performed considering four treatments (inclusion of 0.0%, 0.30%, 0.60%, and 0.90% AY in diets) through the PROC GLM command of SAS (2010). For the growth performance study, a randomized block experimental design with eight replicates and three animals per experimental unit was used. In the study of the total coliform, Escherichia coli, and lactic-acid bacteria counts in the cecum contents, a randomized block design with six replicates and one animal per experimental unit was used, and the microbial count values CFU/g were log₁₀ transformed. For the total and differential counts of leukocytes, we used the experimental design of a randomized block design with repeated measures over time (two blood draws: one before and one at 2 h to 3 h after LPS solution application), eight replicates, and one animal per experimental unit.

RESULTS AND DISCUSSION

No effects of the inclusion of AY (P> 0.05) on daily feed intake were observed in any of the periods studied, nor were any effects on the feed conversion in the periods from 0 to 26 and from 0 to 36 days (Table III). Regression analysis showed a quadratic effect of AY levels on the DWG (y = 0.2652 + 0.0958x – 0.0941x²) and FCR (y = 1.3480 – 0.4247x + 0.4948x²) at 0 to 15 days and, showed a quadratic effect on the DWG at 0 to 26 days (y = 0.3841 + 0.1465x – 0.1688x²) and, at 0 to 36 days (y = 0.4489 + 0.1460x – 0.1726x²) (Table III).

Table III
Mean values of daily feed intake (DFI), daily weight gain (DWG), and feed conversion ratio (FCR) of piglets fed diets with different levels of inclusion of autolyzed yeast (AY).

% of AY in diets
Period	Variable	0.0	0.3	0.6	0.9	Effect	CV (%)
0 to 15 days	DFI (g)	359	353	375	373	NS5	8.87
	DWG (g)	268	279	296	273	Q1	7.05
	FCR	1.35	1.27	1.27	1.37	Q2	6.62
0 to 26 days	DFI (g)	590	616	615	582	NS5	7.98
	DWG(g)	384	412	412	379	Q3	6.15
	FCR	1.54	1.49	1.49	1.53	NS5	5.46
0 to 36 days	DFI (g)	736	766	764	716	NS5	8.30
	DWG(g)	449	476	476	440	Q4	6.12
	FCR	1.64	1.61	1.60	1.62	NS5	4.21

• ¹Quadratic effect (P = 0.0237); ²Quadratic effect (P = 0.0086); ³Quadratic effect (P = 0.0020); ⁴Quadratic effect (P = 0.0052); ⁵NS = Not significant (P > 0.05).

The recommended levels of AY inclusion, calculated on the basis of the regression equations in the present study (between 0.40% and 0.50%), are higher than those suggested by Bael & Roxas (2013) and Molist et al. (2014), who recommended 0.30% and 0.20% brewery hydrolyzed yeast in the diets of weaned piglets, respectively. Although the authors have studied another source of yeast, the species Saccharomyces cerevisiae is the most used in the fermentative processes in sugar cane alcohol distilleries and breweries.

Yeasts are recognized as sources rich in nucleotides (Nu), beta-glucans (β-GL), and mannan-oligosaccharides (MOS) (Aguilar-Uscanga & François 2003, Kogan & Kocher 2007, Lipke and Ovalle 1998), and the AY studied had 3.51% Nu, 22.01% β-GL, and 12.00% MOS. Therefore, its inclusion at levels of 0.3% to 0.9% in the diets of the piglets supplied 105 to 315 ppm Nu, 660 to 1,980 ppm β-GL, and 360 to 1,080 ppm MOS.

Nu have important functions in the body, being precursors of nucleic acids (DNA and RNA), biological regulators, source of energy (ATP) (Lerner & Shamir 2000, Sauer et al. 2011) and, can be synthesized by the “de novo pathway” using amino acids as precursors, with a high energy cost or by the “salvage pathway” from products of digestion of nucleic acids from the diet. Considering certain disease states and periods of limited nutrient intake or even rapidly growing tissues such as the intestinal epithelium, Nu can be considered nutritionally essential because “de novo pathway” synthesis may be insufficient (Hess & Greenberg 2012, Sauer et al. 2011). Thus, their presence in diets may benefit the gastrointestinal morphology and function, the immune system and, the intestinal microbiota of monogastric animals (Sauer et al. 2012).

The conditions imposed by weaning, which usually occurs in commercial farms at approximately 3 to 4 weeks of age result in low feed intake, especially in the first week after weaning (Campbell et al. 2013). This decrease in feed intake is responsible for a reduction in the villi height and alterations in the depth of the intestinal crypts, decreasing the digestive capacity and nutrient uptake (Lallès et al. 2007, Pluske et al. 1997). Therefore, in the present study, the probable re-establishment of intestinal integrity and functions due to the high concentration of Nu in AY may have been a determinant of the better performance of weaned piglets, as the inclusion of Nu in the diets at the level of 500 ppm improved performance and decreased the incidence of diarrhea (Martinez-Puig et al. 2007), and at the 200 ppm level, it increased the final weight and daily weight gain of weaned piglets (Andrade et al. 2016).

Despite the high concentration of β-GL and MOS in yeast cells and the improved growth performance of weaned piglets from the addition of these compounds to their diets (Le Mieux et al. 2003, Li et al. 2006, Mendes et al. 2010, Rozeboom et al. 2005, Tuoi et al. 2016, Valpotić et al. 2016, Wang et al. 2008), this effect can be considered indirect, as the main action attributed to β-GL is the improvement of the immune response (Li et al. 2005, Zhou et al. 2013), and the main action attributed to MOS is the selective action on the intestinal microbiota (Halas & Nochta 2012, White et al. 2002).

The total coliform, Escherichia coli, and lactic-acid bacteria counts in the piglets’ cecum content were not influenced (P> 0.05) by the AY levels in the diets (Table IV). This result partially agrees with those obtained by White et al. (2002), where the addition of 3% dry brewer’s yeast as a source of MOS in the diets of weaned piglets showed no effect on the number of total coliforms and Escherichia coli, despite the increase in the lactobacilli in the feces of animals receiving diets containing yeast. Van der Peet-Schwering et al. (2007) also did not observe alterations in the intestinal microbiota of piglets after weaning when they were provided with diets that included Saccharomyces cerevisiae.

Table IV
Total coliform (TC), Escherichia coli (EC), and lactic-acid bacteria (LAB) counts (log₁₀ CFU/g) in the cecal contents of piglets fed diets with different inclusion levels of autolyzed yeast (AY).

% of AY in diets
Age	Variable	0.0	0.3	0.6	0.9	Effect	CV (%)
61st day	TC EC	8.76 8.75	8.91 8.91	8.54 8.54	7.26 7.22	NS1 NS	15.47 15.40
	LAB	10.34	11.25	10.00	10.48	NS	4.78

• ¹NS = Not significant (P > 0.05).

Beneficial microorganisms exist in the gut, and these can aid in digestion and, by competitive action, reduce the proliferation of pathogenic species that can cause inflammation in the intestinal mucosa and produce toxic metabolites and diseases. Among the beneficial bacteria are those of the genera Lactobacillus and Bifidobacterium, and among the noxious ones are Escherichia coli and those of the genera Clostridium and Salmonella (Fouhse et al. 2016).

The prebiotic action of purified MOS, which has been proven in piglets (Miguel et al. 2004), mainly has been attributed to its nondigestion by the swine, allowing the MOS to serve as a substrate for the growth of beneficial microorganisms and to bind to the fimbriae of pathogenic bacteria, inhibiting the adherence of these bacteria to the cells of the intestinal mucosa and eliminating them in the feces (Halas & Nochta 2012). Although the AY studied showed high concentration of MOS, this component was linked to the proteins of the cell wall, which is also composed of β-glucans and, to a lesser extent, chitins (Magnani & Castro-Gómez 2008, Orlean 2012). For the MOS to exert prebiotic action, the yeast cell must be subjected to mechanical and/or chemical processes that break the cell wall and then treated with proteases, breaking the mannoproteins of the outer cell wall and releasing soluble mannan, which, subsequently, is separated from the insoluble and purified glucans (Yamabhai et al. 2016).

Thus, if yeast cell wall processing is not sufficient to ensure the adequate release of MOS, the prebiotic action of the MOS will be compromised, which may have occurred with the AY assessed in the present study, explaining the absence of effects on the microbiota of the cecum. Another probable explanation for the lack of treatment effects on the bacterial populations in the cecum is related to the low microbiological challenge imposed on the animals during the research; that is, the isolated experimental facilities were cleaned and disinfected, undergoing a sanitary wash before housing the piglets. In addition, the pre-starter diets contained tiamulin as a performance enhancer and included pharmacological doses of zinc (zinc oxide) as an antimicrobial agent.

Interactions (P> 0.05) among the collection, diet time, and diet were not identified on the leukograms of the piglets (Table V). The bacterial LPS used had an effect on the immune system, altering the leukograms of the piglets (P <0.001), as indicated by the values ​​of leukocytes, neutrophils, eosinophils, lymphocytes and monocytes, which were reduced 2 to 3 hours after application (Table V). These results agree with those found by Collier et al. (2011), who found that the leukocyte population was reduced 1 hour after piglets were challenged with LPS and returned to the normal physiological level after 24-hour. This response probably resulted from inflammatory processes induced by the application of the LPS solution, as a rapid migration of leukocytes from the blood to the site of application, resulting in changes in the leukogram (Dhabhar 1998).

Table V
Mean values of the number (10⁶/L) of leukocytes (Leu.), neutrophils (Neu.), eosinophils (Eos.), lymphocytes (Lymph.), monocytes (Mon.), and rods (Rod.) from piglets fed diets with different inclusion levels of autolyzed yeast (AY).

	Leu.	Neu.	Eos.	Lymph.	Mon.	Rod.
Collection (hours after LPS application)
0	19,893a	6,207a	375a	11,565a	915a	0
3	5,784b	845b	37b	4,788b	98b	0
P-value	<.0001	<.0001	<.0001	<.0001	<.0001	-
Diet (% AY)
0.0	12,056	3,695	242	7,628	442	0
0.3	12,737	3,615	162	8,495	403	0
0.6	12,793	2,926	252	8,014	589	0
0.9	13,768	3,056	167	8,570	592	0
P-value	0.4737	0.6698	0.3711	0.6489	0.2123	-
Collection x Diet
P-value	0.8760	0.4777	0.5665	0.6792	0.2841	-

• ^ab Means with different letters in the column differ (P < 0.0001). Not significant (P > 0.05).

As an inducer of the immune response, LPS has been used in research with several animal species, among them swine (Johnson 1997, Saleh et al. 2016). After inoculation, it induces symptoms of acute bacterial infection in piglets, with consequent depression, anorexia, and fever (Klasing & Leshchinsky 2000, Liu et al. 2008). LPS may also exacerbate the production of proinflammatory cytokines and produce tissue damage, with decreased muscle tone and cardiac output resulting in hypotension and poor tissue perfusion and therefore in cell death (Machado et al. 2004).

Among the yeast components, β-GL are considered efficient immunomodulatory agents (Petravić-Tominac et al. 2010, Stier et al. 2014, Volman et al. 2008); however, in this study, increasing the levels of AY inclusion did not alter the white blood cell count of animals challenged or not with 80 μg of LPS/kg of body weight. Possibly, the LPS dose triggered physiological responses that made it difficult to identify the action of AY on the immune system. Furthermore, although it was used to evaluate the immune response of piglets (Lozano et al. 2014, Sugiharto et al. 2014), the leukogram does not seem to be the best way to identify the possible immunomodulatory action of yeast because, in other studies, the action of the hydrolyzed yeast was verified in the concentrations of the acute phase proteins, IgM, and IgG (Molist et al. 2014).

Another consideration is the divergent responses of animals to dietary supplementation with β-GL due to the presentation forms (purified or complexed to the cell wall) of the β-GL, type of processing for production, and levels of inclusion (Rahar et al. 2011, Stier et al. 2014). Although the product used contained 22.01% β-GL, a large part could be bound to the other constituents of the yeast cell wall, impairing the expression of its immunomodulatory potential, as its addition to the diet in its purified form has been shown to be effective in stimulating the immune response (Ledur et al. 2012).

CONCLUSIONS

Autolyzed yeast levels between 0.4% and 0.5% improve the performance of weaned piglets; although its inclusion does not affect the microbiota and the values ​​of total leukocytes and fractions which in turn are reduced by E. coli lipopolysaccharide.

REFERENCES

• AGUILAR-USCANGA B & FRANÇOIS JM. 2003. A study of the yeast cell wall composition and structure in response to growth conditions and mode of cultivation. Lett Appl Microbiol 37: 268-274.
• AMERICAN PUBLIC HEALTH ASSOCIATION. 1992. Compendium of methods for the microbiological examination of foods, 30th ed., Washington: Marvinil, 1208 p.
• ANDRADE C, ALMEIDA VV, SBARDELLA M, PERINA DP, SILVA FL, BERENCHTEIN B, COSTA LB & MIYADA VS. 2016. Performance and intestinal health of weanling pigs fed with dietary nucleotides. Semina: Ciênc Agrár 37: 2181-2192.
• BAEL AB & ROXAS DB. 2013. Effects of yeast-based non-nutritional enhancers on the performance of weanling pigs. Philipp J Vet Anim Sci39: 71-80.
• CAMPBELL JM, CRENSHAW JD & POLO J. 2013. The biological stress of early weaned piglets. J Anim Sci Biotechnol 4: 1-4.
• COLLIER CT, CAROLL JA, BALLOU MA, STARKEY JD & SPARKS JC. 2011. Oral administration of Saccharomyces cerevisiae boulardii reduces mortality associated with immune and cortisol responses to Escherichia coli endotoxin in pigs. J Anim Sci 89: 52-58.
• DHABHAR FS. 1998. Stress-induced enhancement of cell-mediated immunity. Ann N Y Acad Sci 840: 359-372.
• FOUHSE JM, ZIJLSTRA RT & WILLING BP. 2016. The role of gut microbiota in the health and disease of pigs. Animal Frontiers 6: 30-36.
• GOODRIDGE HS, WOLF AJ & UNDERHILL DM. 2009. Beta-glucan recognition by the innate immune system. Immunol Rev 230: 38-50.
• HALAS V & NOCHTA I. 2012. Mannan oligosaccharides in nursery pig nutrition and their potential mode of action. Animals 2: 261-274.
• HAMPSON DJ. 1986. Alterations of piglet small intestine structure at weaning. Res Vet Sci 40: 32-40.
• HESS JR & GREENBERG NA. 2012. The role of nucleotides in the immune and gastrointestinal systems: potential clinical applications. Nutr Clin Pract 27: 281-294.
• HUNTER JB & ASENJO JA. 1988. A structured mechanistic model of the kinetics of enzymatic lysis and disruption of yeast cells. Biotechnol Bioeng 31: 929-943.
• JIANG Z ET AL. 2015. Effects of different forms of yeast Saccharomyces cerevisiae on growth performance, intestinal development, and systemic immunity in early-weaned piglets. J Anim Sci Biotechnol 6: 1-47.
• JOHNSON RW. 1997. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci 75: 1244-1255.
• KLASING KC & LESHCHINSKY TV. 2000. Interactions between nutrition and immunity. In: Gershwin ME, German JB and Keen CL (Eds), Nutrition and Immunology: Principles and Practice, Totowa: Humana Press, p. 363-373.
• KOGAN G & KOCHER A. 2007. Role of yeast cell wall polysaccharides in pig nutrition and health protection. Livest Sci 109: 161-165.
• LALLÈS JP, BOSI P, SMIDT H & STOKES CR. 2007. Weaning - a challenge to gut physiologists. Livest Sci 108: 82-93.
• LE DIVIDICH J & SÈVE B. 2000. Effects of underfeeding during the weaning period on growth, metabolism, and hormonal adjustments in the piglet. Domest Anim Endocrinol 19: 63-74.
• LEDUR VS, RIBEIRO AML, KESSLER AM, GIANFELICI MF, VIEIRA MM, GRANDI J & MACHINSKY TG. 2012. Physiological responses and growth performance of immune challenged piglets supplemented with B-glucans. Arq Bras Med Vet Zootec 64: 434-442.
• LEIBBRANDT VD, EWAN RC, SPEER VC & ZIMMERMAN DR. 1975. Effect of weaning and age at weaning on baby pig performance. J Anim Sci 40: 1077-1080.
• LE MIEUX FM, SOUTHERN LL & BIDNER TD. 2003. Effect of mannan oligosaccharides on growth performance of weanling pigs. J Anim Sci 81: 2482-2487.
• LERNER A & SHAMIR R. 2000. Nucleotides in infant nutrition: a must or an option. Isr Med Assoc J 2: 772-774.
• LI J, LI DF, XING JJ, CHENG ZB & LAI CH. 2006. Effects of beta-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide. J Anim Sci 84: 2374-2381.
• LI J, XING J, LI D, WANG X, ZHAO L, LV S & HUANG D. 2005. Effects of beta-glucan extracted from Saccharomyces cerevisiae on humoral and cellular immunity in weaned piglets. Arch Anim Nutr 59: 303-312.
• LIPKE PN & OVALLE R. 1998. Cell wall architecture in yeast: new structure and new challenges. J Bacteriol 180: 3735-3740.
• LIU D, DING L, SUN J, BOUSSETTA N & VOROBIEV E. 2016. Yeast cell disruption strategies for recovery of intracellular bio-active compounds - A review. Innov Food Sci Emerg Technol 36: 181-192.
• LIU Y, HUANG J, HOU Y, ZHU H, ZHAO S, DING B, YIN Y, YI G, SHI J & FAN W. 2008. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolyssaccharide in weaned pigs. Brit J Nutr 100: 552-560.
• LOZANO AP, POVEDA-PARRA AR, SILVA CA, SANTOS AL, VENÂNCIO EJ, ARANTES VM & NOGUEIRA E. 2014. Effect of L-glutamine levels in piglets diets challenged with Escherichia coli lipopolysacharides. Rev MVZ Cordoba 19: 4328-4337.
• MACHADO PRL, ARAÚJO MIAS, CARVALHO L & CARVALHO EM. 2004.Immune response mechanisms to infections. An Bras Dermatol 79: 647-664.
• MAGNANI M & CASTRO-GÓMEZ RJH. 2008. β-glucan from Saccharomyces cerevisiae: constitution, bioactivity and obtaining. Semina: Ciênc Agrár 29: 631-650.
• MARTINEZ-PUIG D, MANZANILLA EG, MORALES J, BORDA E, PÉREZ JF, PIÑEIRO C & CHETRIT C. 2007. Dietary nucleotide supplementation reduces occurrence of diarrhoea in early weaned pigs. Livest Sci 108: 276-279.
• MENDES CBS, FONTES DO, GUEDES RMC, SILVA FCO, SILVA MA, OLIVEIRA JSV, FERNANDES IS & FONTES FAPV. 2010. Beta-glucan suplementacion in diets for piglets from 21 to 60 days of age. Arq Bras Med Vet Zootec 62: 696-705.
• MIGUEL JC, RODRIGUEZ-ZAS SL & PETTIGREW JE. 2004. Efficacy of a mannan oligosaccharide (Bio-Mos®) for improving nursery pig performance. J Swine Health Prod 12: 296-307.
• MOLIST F, VAN EERDEN E, PARMENTIER HK & VUORENMAA J. 2014. Effects of inclusion of hydrolyzed yeast on the immune response and performance of piglets after weaning. Anim Feed Sci Technol 195: 136-141.
• MORÉS N & AMARAL AL. 2001. Patologias associadas ao desmame. In: X CONGRESSO BRASILEIRO DE VETERINÁRIOS ESPECIALISTAS EM SUÍNOS - ABRAVES, 10, Porto Alegre. Proceedings ... , Concórdia: Embrapa Aves e Suínos, p. 215-224.
• NOGUEIRA ARA ET AL. 2017. Compêndio Brasileiro de Alimentação Animal 2017, 5th ed., São Paulo: Sindirações, 799 p.
• ORLEAN P. 2012. Architecture and biosynthesis of the Saccharomyces cerevisiae cell wall. Genetics 192: 775-818.
• PETRAVIĆ-TOMINAC V, ZECHNER-KRPAN V, GRBA S, SREČEC S, PANJKOTA-KRBAVČIĆ I & VIDOVIĆ L. 2010. Biological effects of yeast β-glucans. Agric Conspec Sci 75: 149-158.
• PLUSKE JR, HAMPSON DJ & WILLIAMS IH. 1997. Factors influencing the structure and function of the small intestine in the weaned pig: a review. Livest Prod Sci 51: 215-236.
• RAHAR S, SWAMI G, NAGPAL N, NAGPAL MA & SINGH GS. 2011. Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res 2: 94-103.
• Rostagno HS, Albino LFT, Donzele JL, Gomes PC, Oliveira RF, Lopes DC, Ferreira AS, Barreto SLT & Euclides RF. 2011. Brazilian tables for poultry and swine: composition of feedstuffs and nutritional requirements, 3rd ed., Viçosa: Universidade Federal de Viçosa, 252 p.
• ROZEBOOM DW, SHAW DT, TEMPELMAN RJ, MIGUEL JC, PETTIGREW JE & CONNOLLY A. 2005. Effects of mannan oligosaccharide and an antimicrobial product in nursery diets on performance of pigs reared on three different farms. J Anim Sci 83: 2637-2644.
• SALEH MAD, AMORIM AB, GRECCO HAT, BERTO DA, PADOVANI CR, ORSI RO & TSE MLP. 2015. Effects of β-(1→3,1→6)-D-glucan and density of diets on the blood profiles of immunologically challenged weaned piglets. Int J Biol Macromol 80: 659-667.
• SALEH MAD, BERTO DA, AMORIM AB, TELLES FG, FACTORI MA & PADOVANI CR. 2016. Influence of dietary (1,3/1,6)-β-D-glucan and diet densities on performance and intestinal morphometry after LPS-induced immunological challenge in weaned piglets. In: Iasinschi A (Ed), Swine`s immunology and immunostimulating effects of beta-glucans, 1st ed., Saarbrücken: Lambert Academic Publishing, p. 38-65.
• SAUER N, EKLUND M, BAUER E, GÄNZLE MG, FIELD CJ, ZIJLSTRA RT & MOSENTHIN R. 2012. The effects of pure nucleotides on performance, humoral immunity, gut structure and numbers of intestinal bacteria of newly weaned pigs. J Anim Sci 90: 3126-3134.
• SAUER N, MOSENTHIN R & BAUER E. 2011. The role of dietary nucleotides in single stomached animals. Nutr Res Rev 24: 46-59.
• SHEN YB, PIAO XS, KIM SW, WANG L, LIU P, YOON I & ZHEN YG. 2009. Effects of yeast culture supplementation on growth performance, intestinal health, and immune response of nursery pigs. J Anim Sci 87: 2614-2624.
• SPREEUWENBERG MA, VERDONK JM, GASKINS HR & VERSTEGEN MW. 2001. Small intestine epithelial barrier function is compromised in pigs with low feed intake at weaning. J Nutr 131: 1520-1527.
• SPRING P, WENK C, DAWSON KA & NEWMAN KE. 2000. The effects of dietary mannaoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of salmonella-challenged broiler chicks. Poultry Sci 79: 205-211.
• STATISTICAL ANALISYS SYSTEM INSTITUTE INC. SAS/STAT® 9.3 User’s guide. Cary: SAS Institute Inc., 2010.
• STIER H, EBBESKOTTE V & GRUENWALD J. 2014. Immune-modulatory effects of dietary yeast beta-1,3/1,6-D-glucan. Nutr J 13: 1-9.
• SUGIHARTO S, HEDEMANN MS & LAURIDSEN C. 2014. Plasma metabolomic profiles and immune responses of piglets after weaning and challenge with E. coli. J Anim Sci Biotechnol 5: 1-8.
• TUOI PT, ASSAVACHEEP P, ANGKANAPORN K & ASSAVACHEEP A. 2016. Effects of β-glucan and mannan-oligosaccharide supplementation on growth performance, fecal bacterial population, and immune responses of weaned pigs. Thai J Vet Med 46: 589-599.
• VALPOTIĆ H ET AL. 2016. Effect of mannan oligosaccharide supplementation on blood and intestinal immune cells, bacteria numbers and performance in weaned pigs. Acta Vet Brno 85: 267-276.
• VAN DER PEET-SCHWERING CM, JANSMAN AJ, SMIDT H & YOON I. 2007. Effects of yeast culture on performance, gut integrity, and blood cell composition of weanling pigs. J Anim Sci 85: 3099-3109.
• VOLMAN JJ, RAMAKERS JD & PLAT J. 2008. Dietary modulation of immune function by beta-glucans. Physiol Behav 94: 276-284.
• WANG Z, GUO Y, YUAN J & ZHANG B. 2008. Effect of dietary beta-1,3/1,6-glucan supplementation on growth performance, immune response and plasma prostaglandin E2, growth hormone and ghrelin in weanling piglets. Asian-Australas J Anim Sci 21: 707-714.
• WHITE LA, NEWMAN MC, CROMWELL GL & LINDEMANN MD. 2002. Brewers dried yeast as a source of mannan oligosaccharides for weanling pigs. J Anim Sci 80: 2619-2628.
• Yamabhai M, Sak-Ubol S, Srila W & Haltrich D. 2016. Mannan biotechnology: from biofuels to health. Crit Rev Biotechnol 36: 32-42.
• YAMAMOTO S, WANG MF, ADJEI AA & AMEHO CK. 1997. Role of nucleosides and nucleotides in the immune system, gut reparation after injury, and brain function. Nutrition 13: 372-374.
• ZHOU TX, JUNG JH, ZHANG ZF & KIM IH. 2013. Effect of dietary β-glucan on growth performance, fecal microbial shedding and immunological responses after lipopolysaccharide challenge in weaned pigs. Anim Feed Sci Technol 179: 85-92.

Publication Dates

• Publication in this collection
  29 July 2020
• Date of issue
  2020

History

• Received
  14 Sept 2018
• Accepted
  26 Feb 2019